Vonoprazan treatment results in fewer episodes of nighttime heartburn and reduces symptom severity in patients with ...
Investor's Business Daily on MSN
Omeros Catapults 154% On A Surprise $2.1 Billion Deal With Novo Nordisk
Omeros stock catapulted Wednesday after Novo Nordisk agreed to pay up to $2.1 billion to license its experimental treatment.
Parasomnias are a fascinating group of clinical disorders associated with undesirable physical and mental phenomena that occur predominantly during sleep. They include sleepwalking (somnambulism), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results